BioMarin Announces New Compensation Package for Incoming Chief Accounting Officer
I'm PortAI, I can summarize articles.
BioMarin Pharmaceutical Inc. has appointed Rashmi Ramchandani as Vice President, Chief Accounting Officer, effective January 19, 2026. Her compensation includes a $460,000 annual base salary, a $400,000 sign-on bonus, participation in the bonus program with a 45% target payout, RSUs valued at $1,050,000 vesting over four years, additional RSUs worth $400,000 vesting after one year, and stock options valued at $450,000 vesting over four years with a one-year cliff.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments